Nagamura-Inoue and He (2014) World Journal of Stem Cells 6(2): 195-202 Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility.
Choudhery et al (2013) Curr Stem Cell Res Ther 8(5): 370-80
Harris (2008) Stem Cell Rev 4:269-274
Beatty PG, Boucher KM, Mori M, Milford EL. Probability of finding HLA-mismatched related or unrelated marrow or cord blood donors. Hum Immunol. 2000;61(8):834-840.
Copeland EA., MD. Hematopoietic Stem-Cell Transplantation. N Engl J Med 2006;354:1813-1826.
Broxmeyer HE. Cord blood hematopoietic stem cell transplantation. (May 26, 2010), StemBook, ed. The Stem Cell Research Community, StemBook, https://www.stembook.org/node/693.
Nietfeld JJ et al. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S. Biol Blood Marrow Transplant 2008;14:316-22.
McDonald S.J., Middleton P: “Effects of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes.” Cochrane Database of Systematic Reviews. 2011. Issue1.
Rocha V, Wagner JE Jr, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee
Pazdur R, Coia L, Hoskins W, et al. Cancer management: a multidisciplinary approach. 1998. Second edition.
Behzad-Behbahani A, Pouransari R, Tabei SZ, et al. Risk of viral transmission via bone marrow progenitor cells versus umbilical cord blood hematopoietic stem cells in bone marrow transplantation. Transplant Proc. 2005;37(7):3211-3212.
Smith AR and Wagner JE.Alternative Hematopoietic Stem Cell Sources for Transplantation: Place of Umbilical Cord Blood. Br J Haematol.2009 October; 147(2): 246–261.
Aldenhoven and Kurtzberg, Cytotherapy 2015; 17:765-774 Cord blood is the optimal graft source for the treatment of pediatric patients with lysosomal storage diseases: clinical outcomes and future directions.
Bizzetto et al, haematological | 2011; 96(1): 134
Matsumoto M.M. and Matthews K.R. A Need for Renewed and Cohesive US Policy on Cord Blood Banking. Stem Cell Rev. 2015 Dec;11(6):789-97. doi: 10.1007/s12015-015-9613-9.
Ballen K. Update on umbilical cord blood transplantation [version 1; referees: 2 approved]. F1000Research 2017, 6(F1000 Faculty Rev):1556 (doi: 10.12688/f1000research.11952.1)
tion: the first 25 years and beyond. Blood. July 25, 2013 vol. 122 no. 4 491-498.
Omar et al, Umbilical Cord Mesenchymal Stem Cells: The New Gold Standard for Mesenchymal Stem Cell-Based Therapies? Tissue Eng Part B Rev. April 2014 (Epub ahead of print).